INTEGRAL DIAGNOSTICS LIMITED (IDX)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:

IDX - INTEGRAL DIAGNOSTICS LIMITED
FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 4.37
Index: ASX300 | ALL-ORDS
Integral Diagnostics is an Australian healthcare services company providing diagnostic imaging services to medical practitioners in Australia and New Zealand. It has been a listed company since 2015.
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$1.86
07 Dec |
OPEN $1.82 |
HIGH $1.90 |
1,101,711 LOW $1.81 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 100% |
OTHER COMPANIES IN THE SAME SECTOR | |||
4DX . AT1 . BRN . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CYC . EBR . EMV . EYE . FPH . HLA . IME . IMR . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI . VHT . VTI . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY22 Actual |
FY23 Actual |
FY24 Forecast |
FY25 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | 10.8 | 7.6 | xxx |
DPS (cps) | xxx | 6.0 | 5.6 | xxx |
EPS Growth | xxx | 54.2% | - 29.7% | xxx |
DPS Growth | xxx | - 14.3% | - 6.7% | xxx |
PE Ratio | xxx | N/A | 24.7 | xxx |
Dividend Yield | xxx | N/A | 3.0% | xxx |
Div Pay Ratio(%) | xxx | 55.8% | 74.0% | xxx |
Last ex-div: 31/08 - ex-div 3.5c (franking 100%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | 10.8 |
DPS All | xxx | xxx | xxx | xxx | xxx | 6.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 440.1 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 160.1 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 71.4 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | 5.69 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | 6.95 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | 3.60 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | 3.09 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | 6.95 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 5.63 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | 14.8 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 17 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 348 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 365 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | 444 M |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 34 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 2.05 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 44.0 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 10.00 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 342 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 58 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | - |
Investments - Total | xxx | xxx | xxx | xxx | xxx | 0 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development

Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
IDX STOCK CHART

FNArena News on IDX
1 |
Rudi’s View: Bear&Bull Market To Continue (?) In 2024Dec 06 2023 - Rudi's View |
2 |
ESG Focus: The Little Big Things – 30-11-2023Nov 30 2023 - ESG Focus |
3 |
Rudi’s View: Quality In Stocks; What Is It Good For?Nov 22 2023 - Rudi's View |
4 |
In Case You Missed It – BC Extra Upgrades & Downgrades – 17-11-23Nov 17 2023 - Weekly Reports |
5 |
Australian Broker Call *Extra* Edition – Nov 16, 2023Nov 16 2023 - Daily Market Reports |
Latest Medical Equipment & Devices News
1 |
Dr Boreham’s Crucible: Pro MedicusOct 23 2023 - Australia |
2 |
Dr Boreham’s Crucible: CyclopharmOct 09 2023 - Small Caps |
3 |
Dr Boreham’s Crucible: PainchekSep 11 2023 - Small Caps |
4 |
Margins Signal Integral Diagnostics RecoverySep 07 2023 - Australia |
5 |
ResMed: Finding A Base?Aug 15 2023 - Technicals |
6 |
August Turns ResMed Into Nigel NoMatesAug 09 2023 - Australia |
7 |
Dr Boreham’s Crucible: Lumos DiagnosticsJun 19 2023 - Small Caps |
8 |
Fisher & Paykel Healthcare: Lower Margin, Higher SpendingMay 30 2023 - Australia |
9 |
Dr Boreham’s Crucible: ImpedimedMay 08 2023 - Small Caps |
10 |
Treasure Chest: ResMed’s Benevolent MonopolyMay 01 2023 - Treasure Chest |